Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals is a development-stage pharmaceutical company focused on developing drugs for oncology and other high unmet medical needs.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Processa Pharmaceuticals, Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases. The company focuses on acquiring de-risked, preclinical- and clinical-stage assets and applying regulatory science to navigate drugs efficiently through FDA approval. Its portfolio includes licensed products such as PCS499, PCS12852, and PCS11T.
History
Processa Pharmaceuticals, Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases. The company focuses on acquiring de-risked, preclinical- and clinical-stage assets and applying regulatory science to navigate drugs efficiently through FDA approval. Its portfolio includes licensed products such as PCS499, PCS12852, and PCS11T.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/processa-pharmaceuticals-inc-united-states · Editorial policy · How profiles are compiled